{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:29:38Z","timestamp":1793744978646,"version":"4.6.1"},"reference-count":10,"publisher":"Centers for Disease Control MMWR Office","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7226a4","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T10:43:43Z","timestamp":1688035423000},"page":"721-727","source":"Crossref","is-referenced-by-count":218,"title":["Illicitly Manufactured Fentanyl\u2013Involved Overdose Deaths with Detected Xylazine \u2014 United States, January 2019\u2013June 2022"],"prefix":"10.15585","volume":"72","author":[{"given":"Mbabazi","family":"Kariisa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Goldberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"key":"key-10.15585\/mmwr.mm7226a4-202306291028-R1","unstructured":"Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Provisional drug overdose death counts. Atlanta, GA: US Department of Health and Human Services, CDC, National Center for Health Statistics; 2023. Accessed June 16, 2023. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"key-10.15585\/mmwr.mm7226a4-202306291028-R2","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.2105\/AJPH.2022.306881","article-title":"Xylazine and overdoses: trends, concerns, and recommendations.","volume":"112","author":"Alexander","year":"2022","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.mm7226a4-202306291028-R3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","article-title":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature.","volume":"240","author":"Ruiz-Col\u00f3n","year":"2014","journal-title":"Forensic Sci Int"},{"key":"key-10.15585\/mmwr.mm7226a4-202306291028-R4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11524-011-9662-6","article-title":"The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico.","volume":"89","author":"Reyes","year":"2012","journal-title":"J Urban Health"},{"key":"key-10.15585\/mmwr.mm7226a4-202306291028-R5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/injuryprev-2020-043968","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010\u20132019.","volume":"27","author":"Johnson","year":"2021","journal-title":"Inj Prev"},{"key":"key-10.15585\/mmwr.mm7226a4-202306291028-R6","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001132","article-title":"Widespread distribution of xylazine detected throughout the United States in healthcare patient samples.","author":"Holt","year":"2023","journal-title":"J Addict Med"},{"key":"key-10.15585\/mmwr.mm7226a4-202306291028-R7","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.3390\/molecules27072057","article-title":"Synthetic cathinones: recent developments, enantioselectivity studies and enantioseparation methods.","volume":"27","author":"Almeida","year":"2022","journal-title":"Molecules"},{"key":"key-10.15585\/mmwr.mm7226a4-202306291028-R8","doi-asserted-by":"publisher","DOI":"10.1111\/1556-4029.15242","article-title":"Identification of the veterinary sedative medetomidine in combination with opioids and xylazine in Maryland.","author":"Sisco","year":"2023","journal-title":"J Forensic Sci"},{"key":"key-10.15585\/mmwr.mm7226a4-202306291028-R9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.15585\/mmwr.mm6634a2","article-title":"Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by Census region\u2014United States, 2006\u20132015.","volume":"66","author":"O\u2019Donnell","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7226a4-202306291028-R10","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1111\/add.15942","article-title":"Rapid changes in illegally manufactured fentanyl products and prices in the United States.","volume":"117","author":"Kilmer","year":"2022","journal-title":"Addiction"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T10:43:46Z","timestamp":1688035426000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/72\/wr\/mm7226a4.htm?s_cid=mm7226a4_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":10,"journal-issue":{"issue":"26","published-online":{"date-parts":[[2023,6,30]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7226a4","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6,30]]},"published":{"date-parts":[[2023,6,30]]}}}